Azevan Pharmaceuticals
Latest round
- Series C
Last raised
- Oct 2013
Total raised
- $2.2M
Investors
- 1
About Azevan Pharmaceuticals
Azevan Pharmaceuticals develops therapeutics aimed at addressing CNS disorders. The company is headquartered in Bethlehem, US. Neal Simon is the CEO.Azevan Pharmaceuticals specializes in creating therapeutics for CNS disorders, particularly stress and neurodegeneration. The flagship product, SRX246, is a selective vasopressin 1a receptor antagonist, undergoing clinical trials for conditions such as Intermittent Explosive Disorder and irritability associated with Huntington’s Disease.Operating within a clinical stage framework, Azevan Pharmaceuticals concentrates on the development and testing of its candidates rather than commercial sales. Revenue generation is expected to occur through partnerships and licensing agreements post-regulatory approval. Collaborations with research institutions and healthcare providers are ongoing, including a partnership with the Department of Defense for a PTSD trial. The company aims to expand its clinical trials and collaboration efforts into new markets, particularly focusing on regions with high prevalence of CNS disorders by 2024. The continued development of its innovative therapeutics is central to Azevan's growth strategy.
Who invested in Azevan Pharmaceuticals
1 investor across 1 round
See all investors in Azevan Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Oct 17, 2013
Amount
$2.2M
Investors
Questions about Azevan Pharmaceuticals
Who invested in Azevan Pharmaceuticals?
Azevan Pharmaceuticals has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Azevan Pharmaceuticals raised?
Azevan Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Azevan Pharmaceuticals last raise money?
Azevan Pharmaceuticals's most recent round on record is a Series C, in Oct 2013.
What does Azevan Pharmaceuticals do?
Azevan Pharmaceuticals develops therapeutics aimed at addressing CNS disorders.
Where is Azevan Pharmaceuticals headquartered?
Azevan Pharmaceuticals is headquartered in Bethlehem, US.
Which VCs invest in companies like Azevan Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Azevan Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Azevan Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.